James S. Evans serves as Executive at MYRIAD GENETICS INC, where they oversee executive responsibilities. Since joining the company, James S. Evans has executed 108 insider transactions totaling $16.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 15, 2007 involved selling 500 shares valued at $27.3K.
James S. Evans currently holds 48,128 shares of MYRIAD GENETICS INC (MYGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James S. Evans has been a net seller of MYGN stock. They have purchased $0 and sold $16.8M worth of shares.
James S. Evans's most recent insider trade was on Oct 15, 2007, when they sold 500 shares at $54.64 per share.
Get notified when new Form 4 filings are submitted
| $54.63 |
| Discretionary |
| Oct 15, 2007 | MYGN | $10.9K | Sale | 200 | $54.61 | Discretionary |
| Sep 13, 2007 | MYGN | $94.1K | Sale | 2,000 | $47.06 | Discretionary |
| Sep 13, 2007 | MYGN | $90.6K | Sale | 1,914 | $47.33 | Discretionary |
| Feb 6, 2007 | MYGN | $208.2K | Sale | 5,626 | $37.00 | Discretionary |
| Feb 6, 2007 | MYGN | $28.9K | Option Exercise | 5,626 | $5.13 | Discretionary |
| Mar 23, 2006 | MYGN | $7.7K | Option Exercise | 1,500 | $5.13 | Discretionary |